NasdaqCM - Nasdaq Real Time Price USD

The Oncology Institute, Inc. (TOIIW)

0.0600
+0.0132
+(28.21%)
As of 11:50:03 AM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
393,412
393,412
324,239
252,483
203,003
Cost of Revenue
339,415
339,415
264,666
200,390
162,155
Gross Profit
53,997
53,997
59,573
52,093
40,848
Operating Expense
114,115
114,115
119,724
124,100
86,706
Operating Income
-60,118
-60,118
-60,151
-72,007
-45,858
Net Non Operating Interest Income Expense
-7,496
-7,496
-6,777
-4,082
-320
Other Income Expense
2,951
2,951
-16,176
75,998
34,580
Pretax Income
-64,663
-64,663
-83,104
-91
-11,598
Tax Provision
--
--
-36
-243
-671
Net Income Common Stockholders
-53,005
-53,005
-67,877
68
-10,628
Average Dilution Earnings
--
--
--
-17,048
--
Diluted NI Available to Com Stockholders
-53,005
-53,005
-67,877
-16,980
-10,628
Total Operating Income as Reported
-60,118
-60,118
-77,018
-81,951
-45,858
Total Expenses
453,530
453,530
384,390
324,490
248,861
Net Income from Continuing & Discontinued Operation
-64,663
-64,663
-83,068
152
-10,927
Normalized Income
-67,979
-67,979
-67,602.7023
-59,490.6300
-42,520.8971
Interest Expense
7,496
7,496
6,777
4,082
320
Net Interest Income
-7,496
-7,496
-6,777
-4,082
-320
EBIT
-57,167
-57,167
-76,327
3,991
-11,278
EBITDA
-50,880
-50,880
-70,454
8,402
-7,937
Reconciled Cost of Revenue
339,415
339,415
264,666
200,390
162,155
Reconciled Depreciation
6,287
6,287
5,873
4,411
3,341
Net Income from Continuing Operation Net Minority Interest
-64,663
-64,663
-83,068
152
-10,927
Total Unusual Items Excluding Goodwill
3,316
3,316
-15,472
75,497
33,534
Total Unusual Items
3,316
3,316
-15,472
75,497
33,534
Normalized EBITDA
-54,196
-54,196
-54,982
-67,095
-41,471
Tax Rate for Calcs
--
--
0
0.0002
0.0001
Tax Effect of Unusual Items
--
--
-6.7023
15,854.3700
1,940.1029
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers